Prosecution Insights
Last updated: October 25, 2026
Application No. 18/730,533

AQUEOUS EMULSIONS CONTAINING SHELLAC PARTICLES AND COATINGS FORMED THEREWITH

Non-Final OA §103
Filed
Jul 19, 2024
Priority
Jan 28, 2022 — provisional 63/304,028 +2 more
Examiner
MAEWALL, SNIGDHA
Art Unit
1612
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Michelman Inc.
OA Round
1 (Non-Final)
59%
Grant Probability
Moderate
1-2
OA Rounds
1y 1m
Est. Remaining
69%
With Interview

Examiner Intelligence

Grants 59% of resolved cases
59%
Career Allowance Rate
630 granted / 1072 resolved
-1.2% vs TC avg
Moderate +10% lift
Without
With
+10.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
37 currently pending
Career history
1133
Total Applications
across all art units

Statute-Specific Performance

§101
1.6%
-38.4% vs TC avg
§103
52.0%
+12.0% vs TC avg
§102
8.6%
-31.4% vs TC avg
§112
18.8%
-21.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1072 resolved cases

Office Action

§103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Detailed Action Restriction/Election Applicant’s election without traverse of Group I, claims 1-2, 4-6 and 8-12 in the reply filed on 08/10/26 is acknowledged. Claims 13-26 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 08/10/26. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1-2, 4-6 and 8-12 are rejected under 35 U.S.C. 103 as being unpatentable over Wilhelm et al. (WO 2006/133928) in view of Bueno et al. (US PG Pub. 2017/0127670). Wilhelm et al. discloses a composition for seed treatment comprising: water as solvent; a binder such as polyvinyl alcohols and shellacs; and plasticizers (see page 16, lines 15-34; page 18, lines 18-20; page 19, lines 33-35; page 22, lines 9-13). The reference teaches use of binder comprising polyvinyl alcohols (see page 16, lines 15-34). Use of polysaccharide is taught on page 16, lines 29-40. The reference teaches plasticizer including polyethylene glycol (see page 18, lines 17-25). The reference teaches pigments (see page 19, lines 2-9). The reference teaches use of surfactants (see page 19, lines 33-35). The weight of the binder ranges from 1% by weight to 15% by weight, see claim 22. Thus, the amount of binders have been optimized by one of ordinary skill in the art for optimum seed coating purposes. Emulsifiers and preservatives are taught on page 19, lines 32-33-35. Agricultural compositions can be in the form of emulsions, suspensions, concentrates, water- dispersing granules and powders, see pages 21-22, lines 1-5. Emulsions are taught on page 23, third paragraph. Water dispersible granules are taught on page 23, last paragraph. Wilhelm et al. do not teach use of particles. Bueno et al. teaches an aqueous seed coating composition: comprising: water; a polymeric binder comprising shellacs and polyvinyl alcohols; and a wax, wherein the wax is selected from the group consisting of paraffin wax, polyolefin wax, natural wax (see claim 1; paragraphs [0037], [0059], [0064]). The reference teaches polymeric binder comprising polyvinyl alcohols (see paragraph [0059]). The reference teaches pigment (see paragraph [0067]). Use of water is taught of 31.6 wt. % water (see paragraph [0090]). Use of wax is taught wherein the wax is selected from the group consisting of paraffin wax; polyolefin wax; and natural wax (see paragraph [0037]). The reference teaches that the composition comprising a biocide and surfactant (see table 1). The reference teaches that the term “hydrophobic and/or water insoluble” as used in this application is meant to describe materials that are primarily non-polar and exhibit limited or no dissolution in water. However, such materials can be suspended in water as molecules or particles, see [0033]. Examples of suitable effect pigments include pearlescent pigment in different particle sizes. Effect pigments having a particle size of 15 μm or less, or a particle size of 60 μm or less may be used. The particle size of the effect pigment is preferably not more than 200 μm, more preferably not more than 100 Usually, the particle size of the effect pigment is 1 μm or more. Another effect pigment can be aluminium. Effect pigments can be used to create an attractive cosmetic look on the seeds, see [0051]. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have utilized the wax/shellac and binder in a particulate format into the emulsion formulation of Wilhelm et al. One of ordinary skill would have been motivated to do so because both the references teach seed treating composition comprising binders including polyvinyl alcohol and shellac and while Wilhelm et al. discloses that agricultural compositions can be in the form of emulsions, suspensions, concentrates, water- dispersing granules and powders, Bueno discloses use of binders and pigments a in a particulate form. Correspondence Any inquiry concerning this communication or earlier communications from the examiner should be directed to SNIGDHA MAEWALL whose telephone number is (571)272-6197. The examiner can normally be reached Monday thru Friday; 8:30 AM to 5PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sahana S. Kaup can be reached on 571-272-6897. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SNIGDHA MAEWALL/Primary Examiner, Art Unit 1612
Read full office action

Prosecution Timeline

Jul 19, 2024
Application Filed
Sep 18, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12766218
HEMOSTATIC, ANTIBACTERIAL, AND HEALING-PROMOTING CLAY MINERAL-BASED BIOMATERIAL AND PREPARATION METHOD THEREOF
2y 9m to grant Granted Oct 20, 2026
Patent 12754116
BIORELEVANT DISSOLUTION MEDIA
4y 9m to grant Granted Oct 06, 2026
Patent 12746304
NANOCOMPOSITE FIBERS WITH A DRAMATIC REDUCTION IN HUMAN PLASMA COAGULATION TIME
5y 2m to grant Granted Sep 29, 2026
Patent 12734497
HIGH AMYLOSE STARCH BASED CAPSULES AND METHOD OF MAKING SAME
5y 4m to grant Granted Sep 15, 2026
Patent 12733639
HESPERALOE EXTRACT FOR FOLIAR USE
2y 9m to grant Granted Sep 15, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
59%
Grant Probability
69%
With Interview (+10.5%)
3y 4m (~1y 1m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1072 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month